Last updated on February 2018

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

Brief description of study

Examine the effectiveness and safety of the abatacept administration in biologic-nave rheumatoid arthritis patients who have moderate disease activity despite treatments with conventional synthetic disease modified anti-rheumatic drugs.

Clinical Study Identifier: NCT02758769

Find a site near you

Start Over